CL
EVH icon

Choreo LLC’s Evolent Health EVH Stock Holding History

Choreo LLC’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,177
Closed -$151K – 1641
2025
Q4 		$151K Sell
37,177
-4,845
-12% -$26.9K ﹤0.01% 1490
2025
Q3 		$356K Buy
42,022
+10,333
+33% +$100K ﹤0.01% 1128
2025
Q2 		$357K Buy
31,689
+334
+1% +$3.07K 0.01% 1074
2025
Q1 		$297K Buy
31,355
+16,543
+112% +$167K ﹤0.01% 1095
2024
Q4 		$163K Buy
14,812
+643
+5% +$11.3K ﹤0.01% 1470
2024
Q3 		$383K Buy
14,169
+340
+2% +$8.76K 0.01% 1051
2024
Q2 		$255K Buy
+13,829
New +$353K ﹤0.01% 1182

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Choreo LLC's EVH Position: Q1 2026 in Review

Choreo LLC sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 37,177 shares — an estimated $151K sold.

Choreo LLC first reported a position in EVH in Q2 2024 and held it in 7 quarters. The position peaked at $383K in Q3 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Choreo LLC reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Choreo LLC sold 37,177 Evolent Health shares in Q1 2026, an estimated $151K.
  • Choreo LLC first reported a position in Evolent Health in Q2 2024 and held it in 7 quarters.
  • Choreo LLC's Evolent Health position peaked at $383K in Q3 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.